Sharecast - Ladbrokes and Coral owner Entain (LON:ENT) was knocked lower by a downgrade to ‘sell’ from ‘buy’ at Goldman Sachs (NYSE:GS). "We now believe the...
LONDON - Barclays (LON:BARC) has made a series of recalibrations to its price targets on a range of FTSE-listed stocks, reflecting a mix of optimism and caution in its latest...
Proactive Investors - Barclays (LON:BARC) Capital has issued an optimistic assessment of AstraZeneca PLC (LON:AZN)'s shares, recommending an 'overweight' position with a target...
AstraZeneca's Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) receives US FDA marketing approval for the treatment of adult patients with hormone receptor...
LONDON - UK stocks rebounded on Friday, with the FTSE 100 and FTSE 250 indices climbing by 1.1% and 1.3% respectively, as investor sentiment improved on the back of economic data...
CAMBRIDGE, UK - AstraZeneca (NASDAQ:AZN) has announced that its recent PACIFIC-2 Phase III trial, which tested the efficacy of Imfinzi in combination with platinum-based...
Benzinga - by Benzinga Insights, Benzinga Staff Writer. In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry...
UK stocks are severely lagging their American counterparts as concerns about the British economy continue. The mid-cap FTSE 250 index has slipped by 5% this year while the...
AstraZeneca (NASDAQ:AZN)'s immunotherapy drug, Imfinzi (durvalumab), has shown significant improvements in progression-free survival (PFS) for liver cancer patients eligible for...
If I don't know anything about this job now, please tell me everything
0
Rizwan baig
0
don't shorts from technical analysis informa will move from 11,158 to 11345.4 today target 🎯so buy quickly. don't short. if downtrend going then strongly buy.
2
don't shorts from analysis AZN will move from now 11,158 today target 11345.78 easily movement🎯so buy quickly.
1
iam new don't know anything doesnt even have a bank account can someone help?